Skip to main content
. Author manuscript; available in PMC: 2006 Jan 25.
Published in final edited form as: Pharmacogenet Genomics. 2005 Apr;15(4):245–256. doi: 10.1097/01213011-200504000-00008

Table 4.

Occurrence of SNPs among FMO2*2 alleles in a Hispanic- and African-American population

Population Exon 3g.7,700_7,702dupGAC Exon 4 g.10,951delG Exon 5 g.13,732C > T Exon 8 g.22,060T > G
Africana, N = 89 27/89 27/89 51/89 27/89
30.3% 30.3% 57.3% 30.3%
(21.0–41.0%)b (21.0–41.0%) (46.4–67.7%) (21.0–41.0%)
Hispanic, N = 276 0/276 31/276 133/276 34/276
0% 11.2% 48.2% 12.3%
(0–1.3%) (7.8–15.6%) (42.2–54.3%) (8.7–16.8%)
a

Results from the African-American population were extracted from Furnes et al. [17].

b

Numbers in parentheses are 95% confidence intervals (Clopper–Pearson binomial) associated with the indicated SNP occurrence.